March 14th, 2011
AHA Offers Qualified Endorsement of Weight-Loss Surgery
Larry Husten, PHD
For the first time, the AHA has offered a qualified endorsement of bariatric surgery. The scientific statement, published in Circulation, states that bariatric surgery is a relatively safe procedure that can lead to long-term weight loss and significantly improve health in appropriately selected obese patients who have been unable to lose weight nonsurgically.
But, said Paul Poirier, the lead author of the statement, in an AHA press release, “it is not an across-the-board endorsement of bariatric surgery for the severely obese. It is a consensus document that provides expert perspective based on the results of recent scientific studies.”
The statement notes that surgical weight loss can “completely reverse established diabetes mellitus in a large percentage of subjects” and results in improvements in lipids, inflammation, nonalcoholic fatty liver disease, hypertension, sleep apnea, and cardiac function. The report states that “there is increasing, although not definitive, evidence that bariatric surgery provides a significant survival benefit.”
Categories: General, Prevention
Tags: bariatric surgery, obesity, weight loss
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
One Response to “AHA Offers Qualified Endorsement of Weight-Loss Surgery”
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Glucocorticoids in Kawasaki Disease — Refining Indications and the Science April 16, 2026Kawasaki disease is the most common cause of acquired heart disease in children in the developed world.1 Although Kawasaki disease manifests with acute, transient systemic signs, its long-term morbidity derives from necrotizing vasculitis that predominantly affects the coronary arteries.2,3 The primary goal of therapy during the...
- Asundexian for Secondary Stroke Prevention April 16, 2026In a placebo-controlled trial involving patients with noncardioembolic ischemic stroke or high-risk TIA, asundexian added to antiplatelet therapy led to a lower risk of ischemic stroke without increasing major bleeding.
- Asundexian for Noncardioembolic Ischemic Stroke April 16, 2026Despite the implementation of efficacious interventions for secondary prevention, patients with ischemic stroke or transient ischemic attack (TIA) remain at substantial residual risk for short- and long-term recurrent ischemic stroke and coronary events.1,2 Approximately three quarters of ischemic strokes or TIAs are noncardioembolic and may be attributable to...
- Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk April 16, 2026Combined oral contraceptives and hormone-replacement therapy increase the risk of venous thromboembolism, although the absolute risk is low. Transdermal estradiol and micronized progesterone carry lower risk.
- Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease April 16, 2026In a randomized trial involving 3208 children with Kawasaki disease, adding prednisolone to standard primary therapy did not reduce the incidence of coronary-artery lesions at 1 month.
- Glucocorticoids in Kawasaki Disease — Refining Indications and the Science April 16, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women

There is no doubt that bariatric surgery is useful in morbidly obese, but the judicious selection of patients ,taking into account their personality profile is of the utmost importance.The so called “complete reversal of diabetes” is yet to be observed on a long term basis.
Competing interests pertaining specifically to this post, comment, or both:
none